An Indian who took ill after a controversial drug trial that went awry has described his experience as 'horrific' and said he was warned to expect nothing worse than headaches and nausea as......
MNCs increasingly turning to emerging destinations in Southeast Asia due to clearer set of procedures, approvals.In 2000, it was projected as the next big thing to happen in healthcare, for its......
Contract research organisationsundertaking clinical trials of drugs on behalf of their multinational pharmaceutical clients will not be able to pass on the blame of trial-related injuries to their......
The US Department of Justice said on Wednesday it had dropped its legal action against Ranbaxy after the the Indian generic drugs maker stepped up co-operation over regulators' concerns about its......
Pharmaceutical major Ranbaxy Labortaories on Wednesday said it remained confident that its products were safe and effective as the US Department of Justice (DoJ) withdrew a legal motion against it......
The United States district court of Maryland has given 60 days time to Ranbaxy to submit all documents sought by the Department of Justice through an information-seeking motion before the court on......